Dr. Salem I. Elkhayat, MD

Dr. Elkhayat practices at NorthBay Medical Center in Fairfield, California, part of NorthBay Healthcare.

Dr. Elkhayat's NPI, 1184073165, was assigned on June 9, 2016. Dr. Elkhayat graduated from The University of Queensland Medical School in 2015. Dr. Elkhayat's Louisiana license number on file is 312700.

Dr. Elkhayat's primary practice is NorthBay Medical Center, at 1200 B Gale Wilson Blvd, Fairfield, CA 94533 in Solano County. The practice phone is (707) 646-5000.

Dr. Elkhayat's primary practice is NorthBay Medical Center in Fairfield, California, part of NorthBay Healthcare. Dr. Elkhayat is also affiliated with Ochsner Medical Center - Kenner. The medical group on file is NorthBay Medical Center. Dmand AI also links Dr. Elkhayat to 7 more medical groups, each named with a free account. Dr. Elkhayat's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elkhayat practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Elkhayat's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Elkhayat is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Elkhayat's licenses on file in 3 states: Louisiana, California and Florida.

CMS data shows 151 Medicare services from Dr. Elkhayat across 3 procedure codes in 2024, for 146 Medicare patients. Medicare paid $18,921 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 146 Medicare patients who saw Dr. Elkhayat in 2024. The largest group is 75 to 84, with 52 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elkhayat's median patient age at 41, with 54% women.

In 2024, Dr. Elkhayat wrote 243 Medicare Part D claims for 147 patients. 89% of them were for generic drugs. CMS names the drug for 97 of them, across 5 drugs with 11 or more claims each, at $646 in total drug cost. In 2023, CMS named 108 claims across 5 drugs.

Dr. Elkhayat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Elkhayat, published from 2009 to 2010. 2009 was the busiest year, with 3. The most frequent topics are Behavior, Animal, Zebrafish and Exploratory Behavior. Dr. Elkhayat has published most often in Behav Brain Res. Dr. Elkhayat's most frequent co-authors are Marco Fulvio Elegante, MD, Brett Kyle Bartels, MD and Thomas Gilder, MD.

CMS Open Payments shows 3 general payments to Dr. Elkhayat from 3 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $110.

Dr. Elkhayat graduated from The University of Queensland Medical School in 2015.

Dr. Elkhayat is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, CMS Medicare and GA State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.